1. Home
  2. PMEC vs FBLG Comparison

PMEC vs FBLG Comparison

Compare PMEC & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMEC
  • FBLG
  • Stock Information
  • Founded
  • PMEC 1984
  • FBLG 2021
  • Country
  • PMEC Singapore
  • FBLG United States
  • Employees
  • PMEC N/A
  • FBLG N/A
  • Industry
  • PMEC
  • FBLG
  • Sector
  • PMEC
  • FBLG
  • Exchange
  • PMEC Nasdaq
  • FBLG NYSE
  • Market Cap
  • PMEC 46.1M
  • FBLG 37.1M
  • IPO Year
  • PMEC 2023
  • FBLG 2024
  • Fundamental
  • Price
  • PMEC $1.18
  • FBLG $0.96
  • Analyst Decision
  • PMEC
  • FBLG Strong Buy
  • Analyst Count
  • PMEC 0
  • FBLG 4
  • Target Price
  • PMEC N/A
  • FBLG $13.00
  • AVG Volume (30 Days)
  • PMEC 61.7K
  • FBLG 259.9K
  • Earning Date
  • PMEC 12-31-2024
  • FBLG 05-14-2025
  • Dividend Yield
  • PMEC N/A
  • FBLG N/A
  • EPS Growth
  • PMEC N/A
  • FBLG N/A
  • EPS
  • PMEC N/A
  • FBLG N/A
  • Revenue
  • PMEC $74,310,000.00
  • FBLG N/A
  • Revenue This Year
  • PMEC N/A
  • FBLG N/A
  • Revenue Next Year
  • PMEC N/A
  • FBLG N/A
  • P/E Ratio
  • PMEC N/A
  • FBLG N/A
  • Revenue Growth
  • PMEC 3.94
  • FBLG N/A
  • 52 Week Low
  • PMEC $0.49
  • FBLG $0.70
  • 52 Week High
  • PMEC $1.40
  • FBLG $11.75
  • Technical
  • Relative Strength Index (RSI)
  • PMEC 51.43
  • FBLG 55.88
  • Support Level
  • PMEC $1.12
  • FBLG $0.70
  • Resistance Level
  • PMEC $1.25
  • FBLG $0.94
  • Average True Range (ATR)
  • PMEC 0.10
  • FBLG 0.08
  • MACD
  • PMEC -0.01
  • FBLG 0.02
  • Stochastic Oscillator
  • PMEC 37.14
  • FBLG 93.37

About PMEC Primech Holdings Ltd.

Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.

About FBLG FIBROBIOLOGICS INC

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Share on Social Networks: